Stuttering priapism after ingestion of alfuzosin.
A patient who presented with priapism after ingestion of alfuzosin is described. He presented with recurrent priapism, which was relieved temporarily after physical exercise. It did not subside with pharmacologic management and was managed surgically using Winter's procedure. It remained quiescent for a short period, only to reappear later. After additional conservative management, he was well enough to be discharged. At 12 months of follow-up, he was well, had no penile fibrosis, was able to have unaided intercourse, and had moderately bothersome lower urinary tract symptoms. This case illustrates that no therapeutic drug is without side effects and emphasizes the need to warn patients appropriately.
Qazi
Hasan A R
HA
Royal Liverpool University Hospital, Liverpool, United Kingdom.
Ananthakrishnan
K
K
Manikandan
Ramaswamy
R
Fordham
Mark V P
MV
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011317:Priapism / Q000139:chemically induced* / Q000628:therapy; D011799:Quinazolines / Q000009:adverse effects*; D001748:Urinary Bladder Neck Obstruction / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; C047638:alfuzosin